<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="74%"></col>
<col width="26%"></col>
<thead>
<tr>
<th align="left" stylecode="Rrule Botrule Lrule Toprule " valign="top">
<content stylecode="bold">Factors</content>
</th>
<th align="left" stylecode="Rrule Botrule Toprule " valign="top">
<content stylecode="bold">Adjusted Dose</content>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="2" stylecode="Botrule" valign="top">
<sup>1</sup>200 mg and 160 mg dose adjustments are obtained only by using the 300 mg or 400 mg strength vials.</td>
</tr>
</tfoot>
<tbody>
<tr>
<td colspan="2" stylecode="Rrule Lrule Toprule Botrule " valign="top">
<paragraph>
<content stylecode="bold">CYP2D6 Poor Metabolizers </content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>CYP2D6 Poor Metabolizers taking concomitant CYP3A4 inhibitors</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>200 mg<sup>1</sup>
</paragraph>
</td>
</tr>
<tr>
<td colspan="2" stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">Patients Taking 400 mg of ABILIFY MAINTENA</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Strong CYP2D6 <content stylecode="bold">
<content stylecode="underline">or</content>
</content> CYP3A4 inhibitors</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>300 mg</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>CYP2D6 <content stylecode="bold">
<content stylecode="underline">and</content>
</content> CYP3A4 inhibitors</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>200 mg<sup>1</sup>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>CYP3A4 inducers</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Avoid use</paragraph>
</td>
</tr>
<tr>
<td colspan="2" stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>
<content stylecode="bold">Patients Taking 300 mg of ABILIFY MAINTENA</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>Strong CYP2D6 <content stylecode="bold">
<content stylecode="underline">or</content>
</content> CYP3A4 inhibitors</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>200 mg<sup>1</sup>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule " valign="top">
<paragraph>CYP2D6 <content stylecode="bold">
<content stylecode="underline">and</content>
</content> CYP3A4 inhibitors</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>160 mg<sup>1</sup>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule " valign="top">
<paragraph>CYP3A4 inducers</paragraph>
</td>
<td stylecode="Rrule Botrule " valign="top">
<paragraph>Avoid use</paragraph>
</td>
</tr>
</tbody>
</table>